⌘K

Login Start Free

Home/Filings/4/0001209191-14-005380

4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-14-005380

CIK 0001411158operating

View on SEC.gov Company Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 6:42 PM ET

Size

6.8 KB

Accession

0001209191-14-005380

Insider Transaction Report

Form 4

Period: 2014-01-27

Anacor Pharmaceuticals, Inc.ANAC

Plattner Jacob j

Senior VP Research

Transactions

Exercise/Conversion
Stock Option (right to buy)
2014-01-27−44,600→ 0 total
Exercise: $0.60From: 2009-06-03Exp: 2015-06-02→ Common Stock (44,600 underlying)
Exercise/Conversion
Common Stock
2014-01-27$0.60/sh+44,600$26,760→ 99,600 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001411158

Filing Metadata

Form type: 4
Filed: Jan 27, 7:00 PM ET
Accepted: Jan 28, 6:42 PM ET
Size: 6.8 KB

View on SEC.gov